Abstract:Supramolecular therapeutic platforms with different morphologies, precise dye/drug ratio, and multiple stimulus responsiveness were constructed by host‐guest interactions. In vitro and in vivo experiments confirmed their excellent cancer cell killing effects after NIR light trigger. More importantly, the whole‐body immune efficacy was activated after synergistic chemo‐photo therapy and the distal tumor was inhibited during the treatment of primary tumor. Malignant tumor has become one of the hellish killers threatening the health of people around the world, its diagnosis and treatment has become the concerns of public. However, the optimal therapeutic dose, undesired side‐effect, and long‐term immune activation were key and bottleneck problems in tumor treatment. Herein, different batches of supramolecular therapeutic platforms, including vesicles, spherical nanoparticles, and cylindrical nanorods, with precise ratios of dye to drug (1:2) and multiple stimulus responsiveness were constructed by host‐guest complexation between cyanine‐camptothecin conjugates (IR780‐CPT2) and β‐cyclodextrin (β‐CD) pendent hydrophilic copolymers. The reduction responsiveness, near‐infrared photothermal conversion and singlet oxygen (1O2) generation performances endowed these platforms excellent cancer cells killing effect in both of in vitro cellular experiments and in vivo mice models. More importantly, without affecting the weight of mice, the maturation of dendritic cells, proliferation of T cells, up‐regulation of high mobility group protein B1, and reduction of immunosuppressive regulatory T cells were detected after employing a synergistic chemo‐photo therapy, demonstrating the body's immune effect was successfully activated. Thus, during the treatment of primary tumor, the distal tumor was also inhibited. We believe this work could provide a distinctive way to fabricate supramolecular theranostic platforms with different morphologies and improve antitumor and antimetastasis capabilities.

Supramolecular cancer photoimmunotherapy based on precise peptide self-assembly design

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Peptide-based supramolecular photodynamic therapy systems: From rational molecular design to effective cancer treatment

Amphiphilic porphyrin-based supramolecular self-assembly for photochemotherapy: From molecular design to application

Tumor-responsive dynamic nanoassemblies for boosted photoimmunotherapy

Construction of All-in-one Peptide Nanomedicine with Photoacoustic Imaging Guided Mild Hyperthermia for Enhanced Cancer Chemotherapy

Multifunctional inorganic nanomaterials for cancer photoimmunotherapy

Enzyme-Instructed Photoactivatable Supramolecular Antigens on Cancer Cell Membranes for Precision-Controlled T-Cell-Based Cancer Immunotherapy

Supramolecular assemblies with aggregation-induced emission for in situ active imaging-guided photodynamic therapy of cancer cells

Full‐active Pharmaceutical Ingredient Nanosensitizer for Augmented Photoimmunotherapy by Synergistic Mitochondria Targeting and Immunogenic Death Inducing

Phototherapeutic effect of transformable peptides containing pheophorbide a on colorectal cancer

Drug-drug conjugates self-assembled nanomedicines triggered photo-/immuno- therapy for synergistic cancer treatments

A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy

Supramolecular Peptide Constructed by Molecular Lego Allowing Programmable Self-Assembly for Photodynamic Therapy

Self-Assembled Platinum Supramolecular Metallacycles Based On A Novel Tadf Photosensitizer For Efficient Cancer Photochemotherapy

Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications

Peptide-Decorated Supramolecules for Subcellular Targeted Cancer Therapy: Recent Advances.

Cancer photo-immunotherapy: from bench to bedside

Polymorphic Supramolecular Therapeutic Platforms with Precise Dye/Drug Ratio to Perform Synergistic Chemo‐Photo Anti‐Tumor Therapy and Long‐Term Immune Protection

Cascaded Multiresponsive Supramolecular Dimer-Engineered Nano-Modulator Enabling Spatiotemporally Adaptable Tumor Immune Microenvironment Remodeling in Photodynamic Immunotherapy

Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancers